Patents by Inventor Jinsong Wu

Jinsong Wu has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11920042
    Abstract: Described herein is an ink solution, comprising: i. a composition having the formula ABX3; ii. a compound having the formula NH2—R1—NH2; and iii. a solvent. Methods for producing polycrystalline perovskite films using the ink solutions described herein in a fast blading process and the use of the films in photoactive and photovoltaic applications are additionally described.
    Type: Grant
    Filed: January 14, 2020
    Date of Patent: March 5, 2024
    Assignee: THE UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL
    Inventors: Jinsong Huang, Guang Yang, Wuqiang Wu
  • Patent number: 11367874
    Abstract: Provided is a Li+battery comprising an anode comprising an anode active material comprising a plurality of transition metal (TM1)-substituted binary transition metal (TM2) oxide nanocrystals, a cathode in electrical communication with the anode, a separator between the anode and the cathode, and an electrolyte in contact with the anode and the cathode. The anode active material, in a lithiated state, is characterized by a three-dimensional network of the TM1 and nanoparticles of Li2O and nanoparticles of the TM2, both types of nanoparticles distributed throughout the network. In a delithiated state, the anode active material is characterized by the network of the TM1 and nanoparticles of an oxide of the TM1 and nanoparticles of an oxide of the TM2, both types of nanoparticles distributed throughout the network. The TM1-substituted binary TM2 oxide may be characterized by a ratio of TM2/TM1 of at least about 5.
    Type: Grant
    Filed: April 13, 2018
    Date of Patent: June 21, 2022
    Assignee: Northwestern University
    Inventors: Jinsong Wu, Vinayak P. Dravid
  • Publication number: 20200075949
    Abstract: Provided is a Li+ battery comprising an anode comprising an anode active material comprising a plurality of transition metal (TM1)-substituted binary transition metal (TM2) oxide nanocrystals, a cathode in electrical communication with the anode, a separator between the anode and the cathode, and an electrolyte in contact with the anode and the cathode. The anode active material, in a lithiated state, is characterized by a three-dimensional network of the TM1 and nanoparticles of Li2O nanoparticles of the TM2, both types of nanoparticles distributed throughout the network. In a delithiated state, the anode active material is characterized by the network of the TM1 and nanoparticles of an oxide of the TM1 and nanoparticles of an oxide of the TM2, both types of nanoparticles distributed throughout the network. The TM1-substituted binary TM2 oxide may be characterized by a ratio of TM2/TM1 of at least about 5.
    Type: Application
    Filed: April 13, 2018
    Publication date: March 5, 2020
    Inventors: Jinsong Wu, Vinayak P. Dravid
  • Patent number: 10581062
    Abstract: Co3O4 nanocubes as can be homogeneously assembled on a few-layer graphene sheet, such a composite as can be used in conjunction with an anode and incorporated into a high energy lithium-ion battery.
    Type: Grant
    Filed: January 14, 2016
    Date of Patent: March 3, 2020
    Assignee: NORTHWESTERN UNIVERSITY
    Inventors: Jinsong Wu, Junming Xu, Vinayak P. Dravid
  • Publication number: 20160204416
    Abstract: Co3O4 nanocubes as can be homogeneously assembled on a few-layer graphene sheet, such a composite as can be used in conjunction with an anode and incorporated into a high energy lithium-ion battery.
    Type: Application
    Filed: January 14, 2016
    Publication date: July 14, 2016
    Inventors: Jinsong Wu, Junming Xu, Vinayak P. Dravid
  • Patent number: 8454969
    Abstract: A soluble tumor necrosis factor receptor 2 (TNFRII) mutant has an amino acid substitution at position 92Glu compared with the wild TNFRII. The mutant improves the cytotoxicity capacity of neutralizing TNFalpha and lymphotoxin. The mutant and fusion protein comprising it are useful for the treatment of TNFalpha and lymphotoxin related diseases.
    Type: Grant
    Filed: January 12, 2009
    Date of Patent: June 4, 2013
    Assignees: Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd., Taizhou Fudan-Zhangjiang Pharmaceutical Co., Ltd.
    Inventors: Yanjun Liu, Tong Yang, Yijun Shen, Jinsong Wu, Fang Wu
  • Publication number: 20110117082
    Abstract: A soluble tumor necrosis factor receptor 2 (TNFRII) mutant has an amino acid substitution at position 92Glu compared with the wild TNFRII. The mutant improves the cytotoxicity capacity of neutralizing TNFalpha and lymphotoxin. The mutant and fusion protein comprising it are useful for the treatment of TNFalpha and lymphotoxin related diseases.
    Type: Application
    Filed: January 12, 2009
    Publication date: May 19, 2011
    Applicants: Shanghai Fudan-Zhangjiang Bio-pharmaceutical Co., Ltd., Taizhou Fudan-Zhangjiang Pharmaceutical Co., Ltd.
    Inventors: Yanjun Liu, Tong Yang, Yijun Shen, Jinsong Wu, Fang Wu
  • Publication number: 20070177688
    Abstract: Systems and methods for performing space time coding are provided. Two vector?matrix encoding operations are performed in sequence to produce a three dimensional result containing a respective symbol for each of a plurality of frequencies, for each of a plurality of transmit durations, and for each of a plurality of transmitter outputs. The two vector?matrix encoding operations may be for encoding in a) time-space dimensions and b) time-frequency dimensions sequentially or vice versa.
    Type: Application
    Filed: November 27, 2006
    Publication date: August 2, 2007
    Inventors: Jinsong Wu, Steven Blostein